A detailed history of Parsons Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Parsons Capital Management Inc holds 28,883 shares of LLY stock, worth $25.9 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
28,883
Previous 28,569 1.1%
Holding current value
$25.9 Million
Previous $16.7 Million 34.92%
% of portfolio
1.55%
Previous 1.2%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $185,950 - $248,775
314 Added 1.1%
28,883 $22.5 Million
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $770,978 - $908,882
1,468 Added 5.42%
28,569 $16.7 Million
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $246,040 - $339,203
-566 Reduced 2.05%
27,101 $14.6 Million
Q2 2023

Aug 04, 2023

BUY
$350.74 - $468.98 $2,104 - $2,813
6 Added 0.02%
27,667 $13 Million
Q1 2023

Apr 17, 2023

SELL
$310.63 - $364.82 $295,098 - $346,579
-950 Reduced 3.32%
27,661 $9.5 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $54,020 - $62,944
-168 Reduced 0.58%
28,611 $10.5 Million
Q3 2022

Oct 26, 2022

SELL
$296.48 - $337.87 $38,838 - $44,260
-131 Reduced 0.45%
28,779 $9.31 Million
Q2 2022

Jul 29, 2022

BUY
$278.73 - $327.27 $16,166 - $18,981
58 Added 0.2%
28,910 $9.37 Million
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $52,570 - $65,331
-224 Reduced 0.77%
28,852 $8.26 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $5,171 - $6,417
-23 Reduced 0.08%
29,076 $8.03 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $140,494 - $172,898
-634 Reduced 2.13%
29,099 $6.72 Million
Q2 2021

Aug 03, 2021

BUY
$180.55 - $233.54 $4,694 - $6,072
26 Added 0.09%
29,733 $6.82 Million
Q1 2021

Apr 28, 2021

BUY
$164.32 - $212.72 $32,042 - $41,480
195 Added 0.66%
29,707 $5.55 Million
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $12,132 - $16,054
-93 Reduced 0.31%
29,512 $4.98 Million
Q3 2020

Oct 29, 2020

BUY
$146.22 - $169.13 $877 - $1,014
6 Added 0.02%
29,605 $4.38 Million
Q2 2020

Aug 10, 2020

SELL
$136.42 - $164.18 $545 - $656
-4 Reduced 0.01%
29,599 $4.86 Million
Q1 2020

May 05, 2020

SELL
$119.05 - $147.35 $37,976 - $47,004
-319 Reduced 1.07%
29,603 $4.11 Million
Q4 2019

Feb 03, 2020

SELL
$106.92 - $132.43 $34,428 - $42,642
-322 Reduced 1.06%
29,922 $3.93 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $83,402 - $90,720
-781 Reduced 2.52%
30,244 $3.38 Million
Q2 2019

Aug 01, 2019

SELL
$110.79 - $129.32 $45,645 - $53,279
-412 Reduced 1.31%
31,025 $3.44 Million
Q1 2019

Apr 26, 2019

SELL
$111.31 - $131.02 $235,198 - $276,845
-2,113 Reduced 6.3%
31,437 $4.08 Million
Q4 2018

Feb 01, 2019

SELL
$105.9 - $118.64 $9,848 - $11,033
-93 Reduced 0.28%
33,550 $3.88 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $18,803 - $23,500
-219 Reduced 0.65%
33,643 $3.61 Million
Q2 2018

Aug 09, 2018

SELL
$75.7 - $86.88 $8,402 - $9,643
-111 Reduced 0.33%
33,862 $0
Q1 2018

May 07, 2018

SELL
$74.21 - $87.6 $77,772 - $91,804
-1,048 Reduced 2.99%
33,973 $2.63 Million
Q4 2017

Feb 02, 2018

SELL
$81.94 - $87.89 $9,996 - $10,722
-122 Reduced 0.35%
35,021 $2.96 Million
Q3 2017

Oct 26, 2017

BUY
$77.07 - $85.54 $2.71 Million - $3.01 Million
35,143
35,143 $3.01 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.